Product Details

VERLAT-T is a sterile, BP/IP-compliant ophthalmic solution. It lowers elevated intraocular pressure effectively. As a result, ophthalmologists commonly prescribe it for glaucoma and ocular hypertension needing dual-mechanism control.

The eye drops combine:

• Latanoprost IP (0.005% w/v) – This prostaglandin analogue increases aqueous humor outflow through the eye’s uveoscleral pathway. Consequently, it lowers intraocular pressure through enhanced fluid drainage.
• Timolol Maleate IP (0.5% w/v, as Timolol) – This non-selective beta-blocker reduces aqueous humor production at its source. Therefore, it complements latanoprost’s outflow-based action through a distinct mechanism.

Together, these two agents combine increased outflow and reduced production for stronger pressure control. So, VERLAT-T suits patients who need more effective intraocular pressure management than a single agent provides. Because of this, ophthalmologists commonly prescribe it once-daily for open-angle glaucoma and ocular hypertension.

Key Features

• The formula meets sterility and BP/IP standards for safe ocular use
• Two complementary mechanisms combine for enhanced pressure control
• Benzalkonium Chloride Solution IP (0.01% w/v) preserves sterility throughout use
• A compact 5ml dropper bottle allows accurate, controlled dosing
• The formula suits hospital, clinic, and retail pharmacy distribution
• A clear “use within one month of opening” note supports safe patient use